| EMA number | EMEA/H/C/006019 |
| ATC code | J07BX03 |
| Authorisation | 24 June 2022 |
| Withdrawn | 12 October 2023 |
| Revision | 6 |
COVID-19 Vaccine (inactivated, adjuvanted) Valneva is indicated for active immunisation to prevent COVID-19 caused by SARS-CoV-2 in individuals 18 to 50 years of age. The use of this vaccine should be in accordance with official recommendations.